Teva Pharmaceutical Industries (TEVA) Amortization of Goodwill (2017 - 2024)

Teva Pharmaceutical Industries (TEVA) has reported Amortization of Goodwill for 3 consecutive years, with $280.0 million the latest figure, recorded in Q4 2024.

• Quarterly Amortization of Goodwill changed N/A year-over-year to $280.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2025 was $280.0 million (down 78.12% YoY) and the FY2024 annual result came in at $1.3 billion, up 82.86% from the prior year.
• Amortization of Goodwill retreated to $280.0 million in Q4 2024 per TEVA's latest filing, from $600.0 million in the prior quarter.
• Over the last five years, Amortization of Goodwill for TEVA reached as high as $600.0 million in Q3 2024 and fell as low as $280.0 million in Q4 2024.